DOI: 10.25881/20728255_2024_19_4_9

Authors

Khubulava G.G.1, Marchenko S.P.1, Rzaeva E.Sh.2, Naumov A.B.3, Sazonov A.B.2

1 Academician I.P. Pavlov First St. Petersburg State Medical University, St. Petersburg

2 Military Medical Academy of S. M. Kirov, St. Petersburg

3 Saint Petersburg State Pediatric Medical University, Saint Petersburg

Abstract

Purpose of the study: to evaluate the results of using a protocol for the prevention of bleeding in cardiac surgical patients with pathology of the aortic valve and aortic root to optimize tactics for preventing bleeding.

Materials and methods: the first group included 185 cardiac surgical patients with pathology of the aortic valve and aortic root, who underwent surgery on the aortic valve, during the treatment of which a bleeding prevention protocol was applied. The second group consisted of 237 cardiac surgical patients with pathology of the aortic valve and aortic root who underwent surgery on the aortic valve, during whose treatment a bleeding prevention protocol was not used. Data were collected on the management tactics of the preoperative, intraoperative and postoperative periods, such as:

  • anamnestic data, results of echocardiographic examination, laboratory data: preoperative level of hemoglobin, fibrinogen;
  • intraoperative level of hemoglobin, fibrinogen, dose of transfused cryoprecipitate, thromboelastometry data, intraoperative blood loss;
  • drainage discharge during 1 day of the postoperative period, frequency of bleeding, resternotomy, and deaths.

Study results: In the second group of patients, the number of cases of intraoperative hypofibrinogenemia was almost 5 times greater than in group 1; out of 237 patients, 62 (26.2%) had a critically low level of fibrinogen. Fibrinogen hemodilution coagulopathy (intraoperative hypofibrinogenemia) was associated with resternotomy: Х2 = 63.375, p = 0, df = 1, HR = 11.686, 95% CI: 5.61-24.33. Complications associated with bleeding were more common in the second group of patients – 44 (18,6%) cases out of 237 operated patients, Х2 = 10,6; р = 0,001, Х2Yates = 9,693; р = 0,002, RR = 2,453, 95% CI: 1,39-4,34. In the first group, there were only 14 (7,6%) cases of complications associated with bleeding out of 185 operated patients. Significant differences were also found in the frequency of resternotomies: in group 1 – 3 (1.6%) cases, in group 2 – 28 (11.8%) Х2 = 15,859; р = 0 (Х2Yates = 14,397, р = 0; р (F) = 0; RR = 7,286, 95% CI: 2,25-23,59). Of 185 operations in group 1, only 3 cases of resternotomy were observed, which corresponds to 1.6% of all patients in group 1. Upon repeated inspection of the surgical wound, surgical sources of bleeding were identified in all 3 cases. Of the 237 operations in group 2, there were 28 cases of repeated revision of the surgical wound. Of the 28 resternotomies, only in 15 cases a surgical source of bleeding was identified, therefore, the remaining 13 cases of bleeding occurred due to coagulopathy. In group 1, there were no cases of resternotomy performed due to hypocoagulable bleeding. A statistically significant association was found between preoperative anemia and resternotomy (x2, p = 0.039, RR = 2.03, 95% CI: 1-4).

Conclusions:

  1. intraoperative hypofibrinogenemia increases the risk of resternotomy 11 times (x2 = 63.375, p = 0, df = 1, RR = 11.686, 95% CI: 5.61-24.33);
  2. preoperative anemia doubles the risk of resternotomy (p = 0,039, ОR = 2.03, 95% CI: 1-4);
  3. when using the bleeding prevention protocol, intraoperative hypofibrinogenemia occurs 5 times less often;
  4. when using the bleeding prevention protocol, complications associated with bleeding are 2.5 times less common: Х2 = 10,6; р = 0,001, Х2Yates = 9,693; р = 0,002, RR = 2,453, 95% CI: 1,39-4,34;
  5. when using a bleeding prevention protocol, the risk of resternotomy is reduced by 7 times: Х2 = 15,859; р = 0 (Х2Yates = 14,397, р = 0; р (F) = 0; RR = 7,286, 95% CI: 2,25-23,59).

Keywords: bleeding, resternotomy, bleeding prevention protocol, aortic valve defects, aortic aneurysm, aortic stenosis.

References

1. Belov DV, Garbuzenko DV, Lukin OP, Anufrieva S.S. Heyde’s syndrome as a rare cause of gastrointestinal bleeding in aortic stenosis patients. Cardiovascular Therapy and Prevention. 2021; 20(1): 59-64. (In Russ.) doi: 10.15829/1728-8800-2021-2503.

2. Gouveia e Melo R, Gonçalo SD, Lopes А, et.al. Incidence and Prevalence of Thoracic Aortic Aneurysms: A Systematic Review and Meta-analysis of Population-Based Studies // Seminars in Thoracic and Cardiovascular Surgery. 2022; 1(34). doi: 10.1053/j.semtcvs.2021.02.029.

3. Frank RD, Lanzmich R, Budde U, et.al. Severe Aortic Valve Stenosis: Sustained Cure of Acquired von Willebrand Syndrome after Surgical Valve Replacement. Clinical and Applied Thrombosis/Hemostasis. 2017; 3(23): 229-234. doi: 10.1177/1076029616660.

4. Garcia LR, Garzesi AM, Tripoli G, et.al. Heyde syndrome treated by conventional aortic valve replacement. Brazilian Journal of Cardiovascular Surgery. 2019; 5(34): 630-632. doi: 10.21470/1678-9741-2019-0004.

5. Avtaeva YN, Melnikov IS, Vasiliev SA, Gabbasov ZA. The role of von Willebrand factor in hemostasis pathology. Atherothrombosis. 2023; 2(12): 79-102. (In Russ.) doi: 10.21518/2307-1109-2022-12-2-79-102.

6. Vincentelli A, Susen S, Le Tourneau T, et.al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003; 349(4): 343-9. doi: 10.1056/NEJMoa022831.

7. Natorska J, Mazur P, Undas A. Increased bleeding risk in patients with aortic valvular stenosis: From new mechanisms to new therapies. Thromb Res. 2016; 139: 85-9. doi: 10.1016/j.thromres.2016.01.016.

8. Khubulava GG, Marchenko SP, Naumov AB, Scarlatescu E, et al. Clinical and hemodynamic features of preoperative examination of patients with aortic stenosis. M.: A. N. Bakulev National Medical Research Center of Cardiovascular Surgery, 2022. 35 p. (In Russ.)

9. Ranucci M, Baryshnikova E, Pistuddi V, et.al. The effectiveness of 10 years of interventions to control postoperative bleeding in adult cardiac surgery. Interactive Cardiovascular and Thoracic Surgery. 2017; 2(24): 196-202. doi: 10.1093/icvts/ivw339.

10. Dyke C, Aronson S, Dietrich W, et.al. Universal definition of perioperative bleeding in adult cardiac surgery. Journal of Thoracic and Cardiovascular Surgery. 2014; 147(5). doi: 10.1016/j.jtcvs.2013.10.070.

11. Biancari F, Kinnunen E-M, Kiviniemi T, et.al. Meta-analysis of the Sources of Bleeding after Adult Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2018; 4(32): 1618-1624. doi: 10.1053/j.jvca.2017.12.024.

12. Khubulava GG, Marchenko SP, Scarlatescu E, Naumov AB, et al. Bleeding in cardiac surgery: diagnosis and treatment of coagulopathy after artificial circulation. Tutorial. SPb., 2020. 34 р. (In Russ.) doi: 10.13140/RG.2.2.36656.58881.

13. Weber CF, Görlinger K, Meininger D, et. al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012; 117(3): 531-47. doi: 10.1097/ ALN.0b013e318264c644.

14. Raphael J, Mazer CD, Subramani S, et.al. Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients. Anesthesia and Analgesia. 2019; 5(129): 1209-1221. doi: 10.1213/ ANE.0000000000004562.

15. Görlinger K, Pérez-Ferrer A, Dirkmann D, et.al. The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management. Korean Journal of Anesthesiology. 2019; 72(4): 297-322. doi: 10.4097/kja.19169.

16. Gielen CL, Grimbergen J, Klautz RJ, et.al. Fibrinogen reduction and coagulation in cardiac surgery: An investigational study. Blood Coagulation and Fibrinolysis. 2015; 6(26): 613-620. doi: 10.1097/MBC.0000000000000307.

17. Bolliger D, Tanaka KA. Which Came First, the Chicken or the Egg? Clinical Dilemmas in Managing Postoperative Bleeding and Decision-making for Re-exploration After Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2018; 32(4): 1625-1626. doi: 10.1053/j.jvca.2018.01.010.

18. Patel PA, Henderson J, Bolliger D,et.al. The Year in Coagulation: Selected Highlights from 2020. Journal of Cardiothoracic and Vascular Anesthesia. 2021; 8(35): 2260-2272. doi: 10.1053/j.jvca.2021.02.057.

19. Hinton JV, Xing Z, Fletcher C, et.al. Association of Perioperative Cryoprecipitate Transfusion and Mortality After Cardiac Surgery. Annals of Thoracic Surgery. 2023; 2(116). doi: 10.1016/j.athoracsur.2023.02.054.

20. Levy JH, Szlam F, Tanaka K, et.al. Fibrinogen and hemostasis: A primary hemostatic target for the management of acquired bleeding. Anesthesia and Analgesia. 2012; 114(2): 261-274. doi: 10.1213/ANE.0b013e31822e1853.

21. Sørensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. British Journal of Haematology. 2010; 149(6): 834-843. doi: 10.1111/j.1365-2141.2010.08208.x.

For citation

Khubulava G.G., Marchenko S.P., Rzaeva E.Sh., Naumov A.B., Sazonov A.B. Results of application of the protocol for the prevention of bleeding in cardiac surgical patients with pathology of the aortic valve and aortic root. Bulletin of Pirogov National Medical & Surgical Center. 2024;19(4):9-18. (In Russ.) https://doi.org/10.25881/20728255_2024_19_4_9